Updated Results of PURE-01 with Preliminary Activity of Neoadjuvant Pembrolizumab in Patients with Muscle-invasive Bladder Carcinoma with Variant Histologies

2019/11/08 by Andrea Necchi, Daniele Raggi, Andrea Gallina +23 · 4 citations
Medicine · #Bladder and Urothelial Cancer Treatments #Cancer Immunotherapy and Biomarkers #Urinary and Genital Oncology Studies

paper · doi:10.1016/j.eururo.2019.10.026

openalex publication_date 2019/11/08 · openalex created_date 2025/10/10 · openalex updated_date 2026/08/01

Citations

• Classification of Surgical Complications

Cited by

• Deciphering Cellular Ecosystems Driving Tumor Progression and Immune Escape from Spatial Transcriptomics and Single-Cell with COMPOTES
• The rapidly evolving paradigm of neoadjuvant immunotherapy across cancer types
• Neoadjuvant and Adjuvant Chemotherapy for Upper Tract Urothelial Carcinoma: A 2020 Systematic Review and Meta-analysis, and Future Perspectives on Systemic Therapy
• European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines